(Q47740451)

English

Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses

scientific article published in August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/16120081

Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/16120081

author name string

Trujillo-Vargas CM

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/16120081

Mayer KD

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/16120081

Bickert T

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/16120081

Palmetshofer A

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/16120081

Grunewald S

5

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/16120081

Ramirez-Pineda JR

6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/16120081

Polte T

7

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/16120081

Hansen G

8

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/16120081

Wohlleben G

9

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/16120081

Erb KJ

10

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/16120081

publication date

1 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/16120081

Clinical & Experimental Allergy

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/16120081

35

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/16120081

8

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/16120081

1003-1013

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/16120081

The pathophysiology of asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

Novel vaccines protecting against the development of allergic disorders: a double-edged sword?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

Allergy, parasites, and the hygiene hypothesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

Regulatory T cells control the development of allergic disease and asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

Cytokines induce the development of functionally heterogeneous T helper cell subsets

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

Influenza A Virus Infection Inhibits the Efficient Recruitment of Th2 Cells into the Airways and the Development of Airway Eosinophilia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

Inhibition of allergic disorders by infection with bacteria or the exposure to bacterial products

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

Atopic disorders: a vaccine around the corner?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

Mycobacterium vaccae administration during allergen sensitization or challenge suppresses asthmatic features.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

Infection with influenza a virus leads to flu antigen-induced cutaneous anaphylaxis in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

Novel IL-12 family members shed light on the orchestration of Th1 responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

Dendritic cell biology and regulation of dendritic cell trafficking by chemokines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

T helper 1 cells and interferon gamma regulate allergic airway inflammation and mucus production

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

Allergen-specific Th1 cells counteract efferent Th2 cell-dependent bronchial hyperresponsiveness and eosinophilic inflammation partly via IFN-gamma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

Type I interferons and their therapeutic role in Th2-regulated inflammatory disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

Mycobacterium vaccae induces a population of pulmonary CD11c+ cells with regulatory potential in allergic mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

Effect of repeated intradermal injections of heat-inactivated Mycobacterium bovis bacillus Calmette-Guérin in adult asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

Usefulness of mycobacteria in redirecting the immune response in atopic disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02287.X

21 January 2018

Identifiers

10.1111/J.1365-2222.2005.02287.X

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/16120081

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/16120081

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47740451&oldid=2169203439"